Brief: Astria Therapeutics Q2 EPS USD -0.45
Aug 7 (Reuters) - Astria Therapeutics Q2 operating expenses USD 15.102 million. * Q2 net income USD -12.566 million * Q2 EPS USD -0.45 * Q2 income from operations USD -15.102 million
Recent news on Astria Therapeutics
See all newsNASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:28 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:28 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 07:59 PM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM